The Medical Marijuana 411 Physician Education for the New York Healthcare Provider Education is an online curriculum is designed to educate physicians to become a practitioner with the New York Medical Marijuana Program. Successful completion of the course meets the requirements set forth by the New York Department of Health Medical Marijuana Program and meets the New York medical practitioner requirement of 4 hour course as outlined in current New York law. Course is available online from October, 1 2022 through September, 30 2023 Estimated time to complete activity: 6 hours If you are a medical group or network and need multi-seat pricing, please call 844.411.0500. Continuing Education Information This continuing education activity is provided through collaboration between the Medical Marijuana 411 (MM411) and AffinityCE. This activity provides continuing education credit for physicians, physician assistants, nurse practitioners, nurses, pharmacists, and pharmacy technicians. A statement of participation is available for other attendees. AffinityCE designates this enduring activity for a maximum of 6 AMA PRA Category 1 Credit™. Physician assistants should claim only the credit commensurate with the extent of their participation in the activity. Activity Accreditation This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AffinityCE and the MM411. AffinityCE is accredited by the ACCME to provide continuing medical education for physicians. NEW YORK LEGAL FRAMEWORK Registered Organizations \tIdentification \tAmounts \tForms \tIManufacturing/Dispensing \tRegistrations \tLength of Issue \tLength of Issue \tReporting \tOther Provisions \tI-STOP Program \tTax Law under Artcle 20-B \tMedical Marihuana Trust Fund \tPenal Law \tJustification \tProhibits Smoking Medical Marijuana Practitioner Information \t \tCertifications \tLicense Requirements \tRegistration with the New York State Department of Health Medical Marijuana Program \tCertification of Patients \tState Health Commerce System \tAdditional Materials and Documents \tCertifying Patients \tRecertifying Patients \tPTSD Guidance \tVerification of Patient Registration Status \tAccessing the PMP Registry \tQualifying Conditions \tOpioid Use as a Qualifying Condition \tCertifying Patients for the Use of Medical Marijuana \t \tMedical Marijuana Data Management System \tHealth Commerce System \tPrescription Monitoring Program \tGuidance for Practitioners \tCoverage for Office Visits Related to Medical Marijuana \tAdditional Resource Links Continuing Education Module 1: History and Legal Landscape \tEvaluate the legal context in which cannabis can be discussed with patients, given it is legal in many states, but still recognized as a federally illegal substance. \tCompare the historical medicinal uses of marijuana to modern resurgence in patient use of medical marijuana. \tAssess the lack of clinical studies related to Schedule 1 classification of marijuana. Module 2: The Endocannabinoid System: \tEvaluate how cannabinoids interact with receptors, based on research conducted since the discovery of the endocannabinoid system. \tInterpret the function of the endocannabinoid system in the regulation of the body. Module 3: Cannabinoids and Terpenes: \tDifferentiate major and minor cannabinoids. \tSummarize how cannabinoids and terpenes affect the endocannabinoid receptor system. Module 4: Studies on Therapeutic Uses: \tAssess the pros and cons of cannabinoids and their effects on various medical conditions. Module 5: Cannabis and Opioids in Chronic Pain Treatment: \tEvaluate the research studies regarding opioids versus cannabinoids in the treatment of the symptoms of chronic pain. Module 6: Side Effects, Chronic Effects and Misuse: \tAnalyze the side effects, contraindications, and safety concerns of medicinal cannabis. \tIdentify signs of abuse, misuse, and chronic effect of marijuana use. The activity is an educational overview of medical cannabis in its current legal context in the US. Currently there are 2.1 million registered medical marijuana patients and there are an estimated 3.5 million patients using medical marijuana nationwide. The constantly changing legal environment in which cannabis can be used in the United States has resulted in confusion for both physicians and patients. As of November 2022, 37 states have legalized medical marijuana. Due to the lack of knowledge of the legality of discussing medical marijuana, physicians, nurses and pharmacists are hesitant to discuss with their patients. The lack of communication between the patient and physician can lead to the patient self-medicating with no guidance from a medical professional. New York Marijuana Legal Overview The Marihuana Regulation & Taxation Act (MRTA) was signed into law on March 31, 2021 legalizing adult-use cannabis (also known as marijuana, or recreational marijuana) in New York State. If you are a health care professional who wishes to recommend medical cannabis, you must be licensed to do so by the State of New York and have to meet the following criteria: \tBe qualified to treat patients with one or more of the qualifying conditions; \tBe licensed, in good standing as a physician and practicing medicine, in the State of New York; \tHave completed an educational course developed by the New York Department of Health (“Department of Health” or “Department”); \tHave registered with the Department of Health to issue patient certifications for medical cannabis. New York requires all physicians seeking to certify patients for medical marijuana to take a two- to four-hour physician education program. Medical Marijuana 411 (MM411, Inc) is approved by the New York State Department of Health Medical Marijuana Program to offer an online New York State Healthcare Provider Education: Medical Use of Marijuana Certification. Earn 6 CE, CME, CNE or CPE credits upon completion, which meets the requirement of a 2 or 4 hour program. Updates to regulations in August 2017 allowed nurse practitioners and physician assistants to certify qualifying patients. These regulations also provided an option for a two hour education course as well as the four hour education course that was already in place. Upon successful completion of that program, practitioners may register with the Medical Marijuana Program (“MMP”) by emailing the course completion certificate (in PDF format) to firstname.lastname@example.org along with the physician’s state license number and Health Commerce System (HCS) User ID. Once validated, practitioners will receive, via e-mail, a link authorizing them to participate in the MMP and issue patient certifications. In issuing certifications to qualifying patients, practitioners must also comply with the following requirements: \tMust consult the Prescription Drug Monitoring Program prior to issuing certification to review patient’s controlled substance history; \tMust retain a copy of each patient’s certification; \tMust report all patient certifications to the Department; \tHave the patient under continued care for his or her serious condition; \tMust not knowingly issue certification to a person with (a) no medical need for it or (b) for a purpose other than the treatment of a qualifying condition as defined by law in the State of New York. Qualifying Conditions \tcancer, \tHIV infection or AIDS, \tamyotrophic lateral sclerosis (ALS), \tParkinson's disease, \tmultiple sclerosis, \tspinal cord injury with spasticity, \tepilepsy, \tinflammatory bowel disease, \tneuropathy, \tHuntington's disease, \tpost-traumatic stress disorder, \tchronic pain (as defined by 10 NYCRR §1004.2(a)(8)(xi)), \tpain that degrades health and functional capability as an alternative to opioid use or substance use disorder. \tThe severe debilitating or life-threatening condition must also be accompanied by one or more of the following associated or complicating conditions: cachexia or wasting syndrome, severe or chronic pain, severe nausea, seizures, or severe or persistent muscle spasms, PTSD or opioid use disorder Dr. Cox has no financial interest to disclose. AffinityCE staff, MMM411 staff, and planning and review committees have no financial interests to disclose. Mitigation of Relevant Financial Relationships AffinityCE adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CME activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.Dr. Jack Cox is a senior healthcare executive with over 25 years’ experience in regional and national senior leadership positions. Areas of expertise and experience include strategic development of performance improvement systems, innovation, clinical program strategic development and implementation, leadership development, large program operations, education, research and national and international publishing and speaking. Dr. Cox is a board certified Family Physician, a fellow of the American Board of Family Practice, a fellow of the American College of Physician Executives & holds a master’s degree in Medical Management from Tulane University. He has been named one of Becker’s Top 100 CMO’s to know in 2014 & 2016 & has authored 4 books.